Liposomal cancer therapy: exploiting tumor characteristics.
about
Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic AgentsThe comparison of protein-entrapped liposomes and lipoparticles: preparation, characterization, and efficacy of cellular uptakeNano delivers big: designing molecular missiles for cancer therapeutics.Size matters: gold nanoparticles in targeted cancer drug delivery.Medium-chain fatty acid nanoliposomes suppress body fat accumulation in mice.Developing therapeutic microRNAs for cancer.Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.Development of cytarabine prodrugs and delivery systems for leukemia treatment.Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.Recent advances in stealth coating of nanoparticle drug delivery systemsOcular delivery systems for topical application of anti-infective agents.Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art.Preparation and in vivo safety evaluations of antileukemic homoharringtonine-loaded PEGylated liposomes.Delivering safer immunotherapies for cancer.Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acidGlioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.Engineering building blocks for self-assembling protein nanoparticlesNanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity.Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy.PET imaging of liposomes labeled with an [18F]-fluorocholesteryl ether probe prepared by automated radiosynthesis
P2860
Q28079607-0408FAF1-21DA-4B31-BBDF-71F9FFD1305BQ30409258-645A748C-11A7-473B-92BF-3175D65D2D99Q30470080-59655D2F-3F4E-4188-81F1-040656D4C88EQ34290392-9AF7DC96-D9A1-4ECE-811D-FD33CFC8CD2DQ36199237-8A0B73B2-9189-42C0-9F5F-21847EB69DA3Q37543146-EFF6D550-F0B7-4E17-A35D-2901D8732220Q37799614-791D1253-9172-4B5C-A013-B96AA66CD3B1Q37801934-4F05066D-7997-4C1A-B568-5CFD9DA7A932Q37947952-FF33E770-E42C-4B90-B35F-35EB09A991AFQ37974590-3F5AB72D-924D-4563-A198-416AF8001C95Q38577846-77B7627B-1A66-46AB-8C8F-15819D19F664Q38693952-68031E53-76B5-4090-87CC-ACCC1B892AABQ38779285-FBE981BB-BF33-4AAA-9B61-F496AAF856A1Q39330984-664FA8C1-CAF5-4CD8-9FCE-B9FCA234067AQ41782832-1F9251C3-FB58-46B0-95A8-D3FE84636F4EQ41807435-894D6F4E-D9CF-47EA-B9F8-324CDDDFFD30Q42049243-91CB35D3-4B69-4B25-BA54-238C491937AEQ42129072-CCFDE727-55EA-4632-A938-598AB31E2574Q42574574-6715900E-0004-448F-806B-7F74E95223C3Q47203993-6790EBCB-36F7-406F-8B2C-3F164B64B4BBQ53132713-CF10CC04-50E3-444F-A46E-DB91201FD971Q57681482-CF92D879-3A16-4F63-B15B-0CDC4CE43247
P2860
Liposomal cancer therapy: exploiting tumor characteristics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liposomal cancer therapy: exploiting tumor characteristics.
@en
Liposomal cancer therapy: exploiting tumor characteristics.
@nl
type
label
Liposomal cancer therapy: exploiting tumor characteristics.
@en
Liposomal cancer therapy: exploiting tumor characteristics.
@nl
prefLabel
Liposomal cancer therapy: exploiting tumor characteristics.
@en
Liposomal cancer therapy: exploiting tumor characteristics.
@nl
P2860
P1476
Liposomal cancer therapy: exploiting tumor characteristics.
@en
P2093
Thomas Kaasgaard
Thomas L Andresen
P2860
P304
P356
10.1517/17425240903427940
P407
P577
2010-02-01T00:00:00Z